Albarico, Ian M.
HRN: 22-35-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2025
CEFTAZIDIME 1GM (VIAL)
02/15/2025
02/22/2025
IV DRIP
2g
Q8
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes